Closed · W81XWH-09-SCIRP-ATTDA · CFDA 12.420 · Discretionary
Spinal Cord Injury Research Program Advanced Technology Therapeutic Development Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- December 10, 2009
- Close date
- 3
- Expected awards
The verdict
Spinal Cord Injury Research Program Advanced Technology Therapeutic Development Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 3
- expected awards
- 12.420
- CFDA program
Archived opportunity record
Spinal Cord Injury Research Program Advanced… is closed (last close December 10, 2009). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed December 10, 2009
Est. Total Funding
$6,720,000
Expected Awards
3
Instrument
Grant
Description
The Advanced Technology/Therapeutic Development Award (AT/TDA) is intended to support demonstration studies of pharmaceuticals (drugs, biologics, and vaccines) and medical devices in preclinical systems and/or the testing of therapeutics and devices in clinical studies. The intent of the Advanced Technology/Therapeutic Development Award is to assess therapeutics and devices for the treatment, prevention, detection, and diagnosis of SCI. The overall goal of this award mechanism is to accelerate the introduction of improved therapies, treatments, devices, or technologies for SCI into the clinical setting by supporting (1) cognitive/behavioral clinical studies, (2) clinical interventions, (3) the generation of the preclinical data (e.g., Good Laboratory Practice [GLP] animal safety and toxicity, identifying endpoints of clinical efficacy or its surrogate in animal models, and data collection sufficient to support an Investigational New Drug [IND] or Investigational Device Exemption [IDE] application) necessary to conduct clinical trials after completion of the proposed research. The proposed studies are expected to be empirical in nature and product-driven and are expected to be at or beyond Biomedical Technology Readiness Level (TRL) 4 (for descriptions of TRL(s) please see pages 126-138 of the document located at http://www.darpa.mil/STO/solicitations/sn07-44/pdf/TRA_Desktop.pdf). All applications must specifically and clearly address the military relevance of the proposed research. Therefore, Principal Investigators (PIs) are strongly encouraged to collaborate and integrate their projects with military and/or VA research laboratories and programs. Each PI must provide a transition plan (including funding and resources) showing how the product will progress to clinical trials and/or delivery to the military market after the successful completion of this award. Applications must include relevant data to support the rationale for the proposed study. These data may be unpublished and/or from the published literature. DOD Spinal Cord Injury Advanced Technology/Therapeutic Development Award 4 Awards may support human studies but may not be used to support clinical trials of medical products to support regulatory submissions for new or expanded indications (i.e., Phase I-IV clinical trials). Awards may not be used to support fundamental basic research. Proposals must include preliminary and/or published data relevant to the hypothesis/aims of the proposed research project. Awards may support human studies but may not be used to support clinical trials of medical products to support regulatory submissions for new or expanded indications (i.e., Phase 1–4 clinical trials). Awards may not be used to support fundamental basic research. Proposals must include preliminary and/or published data relevant to the hypothesis/aims of the proposed research project. Refer to the Application Instructions & General Information, Appendix 6, for helpful information about distinguishing clinical trials and clinical research. PIs seeking funding for a clinical trial should apply to the FY09 SCIRP Clinical Trial Award –Rehabilitation mechanism (for information about this mechanism, see http://cdmrp.army.mil). Partnering PI Option: To foster collaboration and facilitate progress in the SCI research field by combined effort, the FY09 SCIRP is offering a Partnering PI option for this award mechanism. Development of the research plan should involve a reciprocal flow of ideas and information with equal intellectual input from all partners into the design of a single research project. For example, a proposed project in which a partner merely supplies support services, tissue samples, or access to patients will not meet the intent of this option. This award is structured to accommodate up to three PIs. One member of the team will be identified as the Initiating PI, who will be responsible for the majority of the administrative tasks associated with application submission. The other member(s) will be identified as the Partnering PI(s) and will need to complete administrative tasks associated with application submission. Separate awards will be made to each PI’s institution. One Initiating and up to two Partnering PIs may be designated. Additional collaborators may be included, but they will not be designated PIs. Multidisciplinary and multi-institutional projects are allowed. If the project is multi-institutional, PIs should include plans for communication between investigators at each institution. Additionally, participating institutions must be willing to resolve potential intellectual and material property issues and to remove any barriers that might interfere with achieving high levels of cooperation to ensure successful completion of this award. Use of Human Subjects and Human Biological Substances: All DOD-funded research involving human subjects and human biological substances must be reviewed and approved by the USAMRMC Office of Research Protections (ORP), Human Research Protection Office (HRPO), in addition to local IRBs. The HRPO is mandated to comply with specific laws and directives governing all research involving human subjects that is conducted or supported by the DOD. These laws and directives are rigorous and detailed and will require information in addition to that supplied by the local review board. Allow a minimum of 6 months for regulatory review and approval processes for studies involving human subjects. Refer to the Application Instructions & General Information, Appendix 6, for additional information. Encouraged Department of Defense (DOD) Collaboration and Alignment: Military relevance is a key feature of this award. Therefore, PIs are strongly encouraged to collaborate, integrate, and/or align their research projects with military and/or VA research laboratories and DOD Spinal Cord Injury Advanced Technology/Therapeutic Development Award 5 programs. The following websites may be useful in identifying information about ongoing DOD areas of research interest within the FY09 SCIRP topic areas: Defense Technical Information Center http://www.dtic.mil Congressionally Directed Medical Research Programs http://cdmrp.army.mil U.S. Army Medical Research and Materiel Command https://mrmc.amedd.army.mil Air Force Research Laboratory http://www.wpafb.af.mil/afrl Navy and Marine Corps Public Health Center http://www-nehc.med.navy.mil/ U.S. Department of Veterans Affairs, Office of Research and Development www.research.va.gov Office of Naval Research http://www.onr.navy.mil/ U.S. Army Research Laboratory http://www.arl.army.mil U.S. Naval Research Laboratory www.nrl.navy.mil Defense Advanced Research Projects Agency http://www.darpa.mil/ U.S. Army Medical Research Acquisition Activity http://www.usamraa.army.mil Naval Health Research Center http://www.nhrc.navy.mil/ Office of the Under Secretary of Defense for Acquisition, Technology and Logistics http://www.acq.osd.mil/
Catch-all / unrestricted eligibility mark · W81XWH-09-SCIRP-ATTDA
Grants.gov marks Spinal Cord Injury Research Program Advanced… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
Spinal Cord Injury Research Program Advanced… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |